Patrick W. Serruys

Clinical End Points in Coronary Stent Trials

Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease

A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization

A Prospective Natural-History Study of Coronary Atherosclerosis

Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients

From Vulnerable Plaque to Vulnerable Patient

From Vulnerable Plaque to Vulnerable Patient

Consensus Standards for Acquisition, Measurement, and Reporting of Intravascular Optical Coherence Tomography Studies

Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

Updated Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation